NCT04601467 - PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE | Biotech Hunter

Enrollment

243

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

May 27, 2024

Study Completion Date

August 14, 2024

Conditions

Acute Coronary Syndrome

Interventions

DRUG

AZD5718

Oral dose of AZD5718 (tablet) once daily for 12 months

DRUG

Placebo

Oral dose of matching placebo (tablet) once daily for 12 months

Trial Locations (8)

North Shore Hospital, Auckland

Christchurch Heart Institute (CHI), Christchurch

Changi General Hospital (CGH), Singapore

Khoo Teck Puat Hospital (KTPH), Singapore

National Heart Centre Singapore (NHCS), Singapore

National University Heart Centre, Singapore (NUHCS), Singapore

Ng Teng Fong General Hospital (NTFGH), Singapore

Tan Tock Seng Hospital (TTSH), Singapore